DOP052 Vedolizumab vs. ustekinumab for Crohn’s disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
2018 ◽
Vol 12
(supplement_1)
◽
pp. S066-S067
◽
Keyword(s):
2018 ◽
Vol 12
(supplement_1)
◽
pp. S055-S056
◽
Keyword(s):
P600 Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S415-S416
Keyword(s):
Keyword(s):
2017 ◽
Vol 11
(suppl_1)
◽
pp. S292-S293
Keyword(s):
2013 ◽
Vol 7
◽
pp. S88
◽
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S614-S615
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S616-S616
◽